Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes.

about

Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes.

Item

http://www.wikidata.org/entity/Q54936297

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Additional 4-week capecitabine ...... long-term oncologic outcomes.

@en

Additional 4-week capecitabine ...... long-term oncologic outcomes.

@nl

type

Item

label

Additional 4-week capecitabine ...... long-term oncologic outcomes.

@en

Additional 4-week capecitabine ...... long-term oncologic outcomes.

@nl

prefLabel

Additional 4-week capecitabine ...... long-term oncologic outcomes.

@en

Additional 4-week capecitabine ...... long-term oncologic outcomes.

@nl

P1476

Additional 4-week capecitabine ...... long-term oncologic outcomes.

@en

P2093

Ji Yeon Kim

http://www.w3.org/2001/XMLSchema#string

Kyung Ha Lee

http://www.w3.org/2001/XMLSchema#string

Sang Woo Park

http://www.w3.org/2001/XMLSchema#string

P2860

Local Excision Techniques for Rectal Cancer After Neoadjuvant Chemoradiotherapy: What Are We Doing?

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04

Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer.

Chemotherapy with preoperative radiotherapy in rectal cancer.

Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

The mechanism of action of radiosensitization of conventional chemotherapeutic agents.

Role of cell cycle in mediating sensitivity to radiotherapy.

P304

306-311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4174/ASTR.2018.94.6.306

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jin Soo Kim

P577

2018-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29854708

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5976571

http://www.w3.org/2001/XMLSchema#string